Growth through AES Acurian positions itself as part of Accelerated Enrollment Solutions (AES), signaling a strategic transition to integrated enrollment and site services. This presents an opportunity to approach the company with complementary offerings that expand AES capabilities, such as ancillary patient engagement tools, analytics, or sponsor-focused trial acceleration programs that align with AES’ time and budget guarantees.

NAFLD/NASH Focus Recent launches target NAFLD and NASH patient enrollment, indicating a specialization in liver disease trial recruitment. sales conversations can emphasize site network reach, patient tracing, and retention strategies for NAFLD/NASH studies, as well as potential collaborations with CROs or pharmaceutical sponsors pursuing liver disease programs.

Technology Stack Utilizes WordPress, Google Cloud, Pardot, and analytics tools, suggesting a modern digital footprint with marketing automation and data-driven engagement. This implies opportunities to offer enhanced digital enrollment campaigns, patient registries, or predictive analytics to optimize site selection and enrollment timelines.

Recent Leadership Change Executive leadership transition with a new head of global business development joining from Patheon signals evolving client outreach strategies and potential openness to new partnerships. Engage with the business development contact to position value-added enrollment solutions and joint go-to-market initiatives.

Strategic Partnerships Historically collaborated with Synexus and launched integrated site solutions like SynexusPlus, highlighting a precedent for multi-network enrollment strategies. There is an opportunity to propose expanded multi-site enrollment programs, site-fee optimization, or co-developed enrollment models that leverage partnered research site networks.